Megan Koller is an experienced engineer with a multidisciplinary background spanning pharmaceutical, semiconductor, and polymer manufacturing. She began her career contributing to research on one of M4ALL's very first drug targets, dolutegravir, while completing dual bachelor's degrees in Chemical Engineering and Chemistry at VCU! Following graduation, she worked as a process engineer at Micron Technology, where she owned the titanium (Ti) and titanium nitride (TiN) deposition processes within the Chemical Vapor Deposition department. She later became one of the first engineers at Civica Rx, helping to establish a greenfield non-profit pharmaceutical facility focused on addressing critical drug shortages.